Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose versus standard-dose quadrivalent inactivated influenza vaccine in patients living with HIV
TCTR20230501002Phase 3Completed
- Sponsor
- Faculty of Medicine Ramathibodi Hospital, Mahidol University
- Start
- Aug 2023
- Modality
- Whole Inactivated Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of influenza virus quadrivalent inactivated vaccine in influenza, sponsored by Faculty of Medicine Ramathibodi Hospital, Mahidol University. Started Aug 2023; status: completed.
02
Drugs
influenza virus quadrivalent inactivated vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on TCTR20230501002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20230501002.